Dr. Wolmark is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2 Allegheny Center #1200
University of Pittsburgh
Pittsburgh, PA 15212Phone+1 412-339-5322Fax+1 412-697-4872- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 1978 - 1979
- Clinical Center at the National Institutes of HealthFellowship, Complex General Surgical Oncology, 1976 - 1978
- UPMC Medical Education (Pittsburgh)Residency, Surgery, 1974 - 1976
- McGill University Faculty of MedicineClass of 1970
Certifications & Licensure
- NY State Medical License 1978 - Present
- PA State Medical License 1973 - 2024
- MD State Medical License 1976 - 1993
- DC State Medical License 1977 - 1979
Awards, Honors, & Recognition
- Fellow (FRCSC) Royal College of Physicians and Surgeons of Canada, 1976
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer Start of enrollment: 1998 Jun 01
- Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes Start of enrollment: 1999 Mar 01
- Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer Start of enrollment: 1999 May 01
- Join now to see all
Publications & Presentations
PubMed
- Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial.Eleftherios P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K Chia, Adam M Brufsky, Janice ...> ;Clinical Cancer Research. 2024 Feb 20
- Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).Charles E Geyer Jr, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puha...> ;Journal of Clinical Oncology. 2024 Apr 20
- Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer.Lujia Chen, Ying Wang, Chunhui Cai, Ying Ding, Rim S Kim, Corey Lipchik, Patrick G Gavin, Greg Yothers, Carmen J Allegra, Nicholas J Petrelli, Jennifer Marie Suga, Jud...> ;Journal of Clinical Oncology. 2024 Feb 5
- Join now to see all
Journal Articles
- 21-Gene Assay as Predictor of Chemotherapy Benefit in HER2-Negative Breast CancerEleftherios P Mamounas, Frederick L Baehner, Norman Wolmark, D Lawrence Wickerham, Nature
Press Mentions
- Dan Hayes Witnessed Cancer History, Now He Is Documenting It in a PodcastJune 4th, 2021
- Walter Lawrence, 95, Reflects on the National Cancer Act, Medicine, Social Justice, COVID-19, and Richmond’s Vanishing MonumentsAugust 6th, 2020
- 21-Gene Recurrence Score for Prognosis and Prediction of Taxane Benefit After Adjuvant Chemotherapy plus Endocrine Therapy: Results from NSABP B-28/NRG OncologyNovember 11th, 2019
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- UPMC Presbyterian ShadysidePittsburgh, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: